AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2013
Nov 25, 2013
29875_dirs_2013-11-25_63f23d8f-2ab0-4776-9ea3-511bda3182a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2013-11-22
Reporting Person: Boratto Eva C (SVP, Cont & Chief Acct Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-22 | Common Stock | M | 6654 | $45.07 | Acquired | 19331.7198 | Direct |
| 2013-11-22 | Common Stock | S | 6654 | $66.50 | Disposed | 12677.7198 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-22 | Stock Option | $45.07 | M | 6654 | Disposed | 2019-04-02 | Common Stock (6654) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (pep) | 6968.6813 | Direct |
| Common Stock (restricted) | 19448 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $34.96 | 2018-04-01 | Common Stock (12058) | 12058 | Direct |
| Stock Option | $30.16 | 2020-07-19 | Common Stock (44214) | 44214 | Direct |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (17703) | 17703 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F4: Option became exercisable in three equal annual installments, commencing 7/19/2013.
F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2014.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3